Author information from the last article
Kjell Heuser er ph.d., spesialist i nevrologi, forskningsgruppeleder og overlege ved Nevrologisk avdeling, Oslo universitetssykehus, Rikshospitalet. Han er tilknyttet fagnettverket EpilepsiNett og er styremedlem i Norsk epilepsiselskap.
Articles by Kjell Heuser
Treating status epilepticus in adults
- Kjell Heuser,
- Morten Horn,
- Christian Samsonsen,
- Line Bédos Ulvin,
- Ketil Berg Olsen,
- Kjersti Nesheim Power,
- Gyri Veiby,
- Ellen Molteberg,
- Bernt Engelsen,
- Erik Taubøll
19.03.2024:
This clinical review examines the treatment of status epilepticus, a condition in which epileptic seizures are prolonged and pose a significant risk of brain damage and death. International guidelines recommend the use of benzodiazepines as first-line treatment, and these should be administered...
Temporal lobe epilepsy
- Oliver Henning,
- Kjell Heuser,
- Vilde Stangeby Larsen,
- Eli Berit Kyte,
- Hrisimir Kostov,
- Pål Bache Marthinsen,
- Arild Egge,
- Kristin Å. Alfstad,
- Karl O. Nakken
30.01.2023:
The temporal lobes are the part of the brain most likely to give rise to epileptic seizures. Seizures originating in the temporal lobes vary greatly in character; some may be so unusual that they are not even recognised as epileptic. For patients who have been diagnosed with hippocampal sclerosis...
COVID-19 and epilepsy
- Kjell Heuser,
- Toni Christoph Berger,
- Oliver Henning,
- Sigrid Svalheim,
- Jørn Mandla Sibeko,
- Karl O. Nakken,
- Erik Taubøll
28.06.2021:
Can COVID-19 cause epilepsy, or increase the tendency to seizures in those with epilepsy? Is it safe for persons with epilepsy to be vaccinated against COVID-19? The Epilepsy Association's advisory service has noted a marked increase in enquiries since the outbreak of the pandemic. Patients and...
The role of glial cells in epilepsy
- Kjell Heuser,
- Karolina Szokol,
- Erik Taubøll
14.01.2014:
Epilepsy is perhaps the most complex brain disorder. Despite increasing knowledge of the condition and the availability of a multitude of drugs, one third of patients experience repeated and debilitating seizures (1). Currently, almost all anti-epileptic drugs are targeted at neurons, mainly at...